John A. MacKay earned his B.A. in Chemistry at the St. Lawrence University. He also earned his Ph.D. At the University of Vermont, where he focused on Inorganic Chemistry and on the synthesis of cancer fighting compounds. After working in teaching positions at the University of Vermont, Lyndon State College, and Davidson College, John went on to join Waters Corporation in 1983.View the profile
Serving the rapidly growing bio-health start-up scene as committed partner for drug development and analytical needs.View the profile
Many SMBs know that they need and they want to start "marketing", but they don't know where or how to start. With over 20 years of B2B marketing experience in a range of industries, I am especially skilled at creating strategic plans that integrate traditional methodology with digital approaches. Specialized in serving SMB, I create the framework and processes needed to build an exceptional program that exceeds lead generation, brand awareness and engagement benchmarks.View the profile
About the talk
The cannabis industry is ever evolving with increasing numbers of stakeholders looking to cash in on the biggest trends. To maintain legitimacy, producers must work tirelessly to ensure their products are free from residual solvents, pesticides, heavy metals and other harmful additives. It is also crucial for consumers to know about potency as well as the terpenoid and cannabinoid content of their products. This panel will explore cutting-edge methodologies, legal requirements and the importance of 3rd party testing in the cannabis industry.
00:50 Third-party laboratory
04:08 Sugar is the trigger in CBD
09:40 Analytical chemistry
13:55 How do you need to test
18:55 Conversation about your experience
28:45 Make the assumption
30:00 Get the results of testing back
My name is John McKay and I spent twenty-nine years it at Waters and was happy when Shawn arrived because I had someone else who knew something about the supercritical fluid chromatography. And and that was a good Ally. So I leaned on him a lot and then in 2017. I left them. I left Waters because I didn't want to come and then I've been able to stay on that track and I've been working on the trajectory and seeing if I can speed it up. And so this is one of the opportunities I have. So if I have an opportunity to making less friends and people who
never want to talk to me again, I think that this is going to work. So when you when you move into to the Laboratories how many people have had a how many how many people have had a wonderful experience with a third-party laboratory where you at least gave them to difference in the same sample and you came back with a bat with a different answer not a fan of different answer that it's so unique. I know and so and so I always hear that throughout my trouble. So I'm I'm actually a consultant so I just go everywhere and and then just might my ideas is I'm a seagull
I apply in I should all over you when I fly away. But during that process I hear about the different things that are happening with the Laboratories and in knowing Chris Adele who's go to laboratory in the east coast and so he lose his business every year because he gives the right answer that there's there's repercussions to that and the same thing happens when I'm talking to customers. They will go to one laboratory knowing that that's where there are India's and they will go to another laboratory to get a higher or a result that they're looking for for their for their ingredients.
So that that is the marketplace and so when you have legitimate people like this up on stage and stuff, it gives us an opportunity to say what Canal can happen. I had a I had a couple things that are kind of demonstrated when I when I'm doing a laboratory just
Buy this talk
Buy this video
With ConferenceCast.tv, you get access to our library of the world's best conference talks.